In recent years, almost 11% of women taking chemical abortion medications have experienced serious adverse health events such as infection, bleeding and sepsis, according to reports from a conservative group reviewing insurance claim data.
The American Foundation for Restoration has a team of board-certified alumni clinicians through more than 865,000 insurance claims related to chemical abortions from 2017 to 2023, with at least 10.9% of the patients found to have resulted in serious adverse health events.
In the final year of the review, that percentage jumped to 11.2% of chemical abortions with significant adverse events, affecting tens of thousands of women.
The review also found that the rate of severe health complications was “about 22 times higher” than that listed on the popular abortion pyrumifepristone label originally approved by the Food and Drug Administration (FDA) in 2000.
In 2023, the brand Mifeprex FDA stated in a clinical trial cited earlier Less than 0.5% She suffered from complications in women.
“Our data show that chemical abortion poses greater risks for women in real-world clinical use than revealed in the Mifepristone clinical trial, and that the rate of significant adverse events from chemical abortion regimens has continued to grow in recent years,” the report concluded.
The American Foundation for Restoration has identified at least 692,873 patients who had 865,727 chemical abortions between 2017 and 2023 for review.
The FDA initially lost mifepristone for chemical abortions up to seven weeks from pregnancy. This is a time frame extended to 10 weeks under former President Barack Obama.
Former President Joe Biden opened the door online for FDA approval of the Mifepristone prescription, which the Supreme Court upheld in a unanimous ruling last year.
Dr. Christina Francis, a board-certified obstetrician and CEO of the American Society for Life Promotion, said the Mifeprex post label underestimates potentially serious health complications, including sepsis, blood transfusions, hospitalization, infection, bleeding, ruptured uterine, and epithelial pregnancy and death.
“This should serve as an emergency safety signal for the FDA and is more consistent with what I see in clinical practice,” Francis said.
“As a board-certified alumni/Gyn who has practiced for about 20 years, I have lied about the safety of abortion medications and cared for many women with significant complications,” she continued.
“Women deserve sufficient informed consent for the risks of these drugs, and this data shows that more than one in 10 women taking them suffer from severe complications,” she added.
“This is a public health crisis and should be investigated further immediately by the FDA, particularly in light of the systematic removal of medical surveillance from these drugs.”
The American Restoration Foundation was founded by Doug Truax, a former Senate Republican candidate in Illinois, founder and CEO of the health insurance group Everlong Group Medical Captive Services.
